LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: Functional characterization of cooperating MGA mutations in RUNX1::RUNX1T1 acute myeloid leukemia.

    Thomas, Melvin E / Qi, Wenqing / Walsh, Michael P / Ma, Jing / Westover, Tamara / Abdelhamed, Sherif / Ezzell, Lauren J / Rolle, Chandra / Xiong, Emily / Rosikiewicz, Wojciech / Xu, Beisi / Loughran, Allister J / Pruett-Miller, Shondra M / Janke, Laura J / Klco, Jeffery M

    Leukemia

    2024  Volume 38, Issue 5, Page(s) 991–1002

    Abstract: MGA (Max-gene associated) is a dual-specificity transcription factor that negatively regulates MYC-target genes to inhibit proliferation and promote differentiation. Loss-of-function mutations in MGA have been commonly identified in several hematological ...

    Abstract MGA (Max-gene associated) is a dual-specificity transcription factor that negatively regulates MYC-target genes to inhibit proliferation and promote differentiation. Loss-of-function mutations in MGA have been commonly identified in several hematological neoplasms, including acute myeloid leukemia (AML) with RUNX1::RUNX1T1, however, very little is known about the impact of these MGA alterations on normal hematopoiesis or disease progression. We show that representative MGA mutations identified in patient samples abolish protein-protein interactions and transcriptional activity. Using a series of human and mouse model systems, including a newly developed conditional knock-out mouse strain, we demonstrate that loss of MGA results in upregulation of MYC and E2F targets, cell cycle genes, mTOR signaling, and oxidative phosphorylation in normal hematopoietic cells, leading to enhanced proliferation. The loss of MGA induces an open chromatin state at promoters of genes involved in cell cycle and proliferation. RUNX1::RUNX1T1 expression in Mga-deficient murine hematopoietic cells leads to a more aggressive AML with a significantly shortened latency. These data show that MGA regulates multiple pro-proliferative pathways in hematopoietic cells and cooperates with the RUNX1::RUNX1T1 fusion oncoprotein to enhance leukemogenesis.
    MeSH term(s) Animals ; Core Binding Factor Alpha 2 Subunit/genetics ; Mice ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/pathology ; Humans ; RUNX1 Translocation Partner 1 Protein/genetics ; Mutation ; Transcription Factors/genetics ; Mice, Knockout ; Cell Proliferation ; Oncogene Proteins, Fusion/genetics ; Gene Expression Regulation, Leukemic ; DNA-Binding Proteins ; Proto-Oncogene Proteins
    Chemical Substances Core Binding Factor Alpha 2 Subunit ; RUNX1 Translocation Partner 1 Protein ; RUNX1 protein, human ; RUNX1T1 protein, human ; Transcription Factors ; Oncogene Proteins, Fusion ; MTG8 protein, mouse ; DNA-Binding Proteins ; Proto-Oncogene Proteins
    Language English
    Publishing date 2024-03-07
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-024-02193-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Functional Characterization of Cooperating MGA Mutations in RUNX1::RUNX1T1 Acute Myeloid Leukemia.

    Klco, Jeffery / Thomas, Melvin / Qi, Wenqing / Walsh, Michael / Ma, Jing / Westover, Tamara / Abdelhamed, Sherif / Ezzell, Lauren / Rolle, Chandra / Xiong, Emily / Rosikiewicz, Wojciech / Xu, Beisi / Pruett-Miller, Shondra / Loughran, Allister / Janke, Laura

    Research square

    2023  

    Abstract: MGA (Max-gene associated) is a dual-specificity transcription factor that negatively regulates MYC-target genes to inhibit proliferation and promote differentiation. Loss-of-function mutations ... ...

    Abstract MGA (Max-gene associated) is a dual-specificity transcription factor that negatively regulates MYC-target genes to inhibit proliferation and promote differentiation. Loss-of-function mutations in
    Language English
    Publishing date 2023-09-22
    Publishing country United States
    Document type Preprint
    DOI 10.21203/rs.3.rs-3315059/v1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Mutant Samd9l expression impairs hematopoiesis and induces bone marrow failure in mice.

    Abdelhamed, Sherif / Thomas, Melvin E / Westover, Tamara / Umeda, Masayuki / Xiong, Emily / Rolle, Chandra / Walsh, Michael P / Wu, Huiyun / Schwartz, Jason R / Valentine, Virginia / Valentine, Marcus / Pounds, Stanley / Ma, Jing / Janke, Laura J / Klco, Jeffery M

    The Journal of clinical investigation

    2022  Volume 132, Issue 21

    Abstract: SAMD9 and SAMD9L germline mutations have recently emerged as a new class of predispositions to pediatric myeloid neoplasms. Patients commonly have impaired hematopoiesis, hypocellular marrows, and a greater risk of developing clonal chromosome 7 ... ...

    Abstract SAMD9 and SAMD9L germline mutations have recently emerged as a new class of predispositions to pediatric myeloid neoplasms. Patients commonly have impaired hematopoiesis, hypocellular marrows, and a greater risk of developing clonal chromosome 7 deletions leading to MDS and AML. We recently demonstrated that expressing SAMD9 or SAMD9L mutations in hematopoietic cells suppresses their proliferation and induces cell death. Here, we generated a mouse model that conditionally expresses mutant Samd9l to assess the in vivo impact on hematopoiesis. Using a range of in vivo and ex vivo assays, we showed that cells with heterozygous Samd9l mutations have impaired stemness relative to wild-type counterparts, which was exacerbated by inflammatory stimuli, and ultimately led to bone marrow hypocellularity. Genomic and phenotypic analyses recapitulated many of the hematopoietic cellular phenotypes observed in patients with SAMD9 or SAMD9L mutations, including lymphopenia, and pinpointed TGF-β as a potential targetable pathway. Further, we observed nonrandom genetic deletion of the mutant Samd9l locus on mouse chromosome 6, mimicking chromosome 7 deletions observed in patients. Collectively, our study has enhanced our understanding of mutant Samd9l hematopoietic phenotypes, emphasized the synergistic role of inflammation in exaggerating the associated hematopoietic defects, and provided insights into potential therapeutic options for patients.
    MeSH term(s) Mice ; Animals ; Tumor Suppressor Proteins/genetics ; Tumor Suppressor Proteins/metabolism ; Hematopoiesis/genetics ; Germ-Line Mutation ; Transcription Factors/genetics ; Chromosome Deletion ; Neoplasms/genetics ; Syndrome ; Bone Marrow Failure Disorders
    Chemical Substances Tumor Suppressor Proteins ; Transcription Factors
    Language English
    Publishing date 2022-11-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3067-3
    ISSN 1558-8238 ; 0021-9738
    ISSN (online) 1558-8238
    ISSN 0021-9738
    DOI 10.1172/JCI158869
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors.

    Barajas, Juan M / Rasouli, Milad / Umeda, Masayuki / Hiltenbrand, Ryan / Abdelhamed, Sherif / Mohnani, Rebecca / Arthur, Bright / Westover, Tamara / Thomas, Melvin E / Ashtiani, Minoo / Janke, Laura J / Xu, Beisi / Chang, Ti-Cheng / Rosikiewicz, Wojciech / Xiong, Emily / Rolle, Chandra / Low, Jonathan / Krishan, Reethu / Song, Guangchun /
    Walsh, Michael P / Ma, Jing / Rubnitz, Jeffrey E / Iacobucci, Ilaria / Chen, Taosheng / Krippner-Heidenreich, Anja / Zwaan, Christian M / Heidenreich, Olaf / Klco, Jeffery M

    Blood

    2023  Volume 143, Issue 7, Page(s) 619–630

    Abstract: Abstract: UBTF tandem duplications (UBTF-TDs) have recently emerged as a recurrent alteration in pediatric and adult acute myeloid leukemia (AML). UBTF-TD leukemias are characterized by a poor response to conventional chemotherapy and a transcriptional ... ...

    Abstract Abstract: UBTF tandem duplications (UBTF-TDs) have recently emerged as a recurrent alteration in pediatric and adult acute myeloid leukemia (AML). UBTF-TD leukemias are characterized by a poor response to conventional chemotherapy and a transcriptional signature that mirrors NUP98-rearranged and NPM1-mutant AMLs, including HOX-gene dysregulation. However, the mechanism by which UBTF-TD drives leukemogenesis remains unknown. In this study, we investigated the genomic occupancy of UBTF-TD in transformed cord blood CD34+ cells and patient-derived xenograft models. We found that UBTF-TD protein maintained genomic occupancy at ribosomal DNA loci while also occupying genomic targets commonly dysregulated in UBTF-TD myeloid malignancies, such as the HOXA/HOXB gene clusters and MEIS1. These data suggest that UBTF-TD is a gain-of-function alteration that results in mislocalization to genomic loci dysregulated in UBTF-TD leukemias. UBTF-TD also co-occupies key genomic loci with KMT2A and menin, which are known to be key partners involved in HOX-dysregulated leukemias. Using a protein degradation system, we showed that stemness, proliferation, and transcriptional signatures are dependent on sustained UBTF-TD localization to chromatin. Finally, we demonstrate that primary cells from UBTF-TD leukemias are sensitive to the menin inhibitor SNDX-5613, resulting in markedly reduced in vitro and in vivo tumor growth, myeloid differentiation, and abrogation of the UBTF-TD leukemic expression signature. These findings provide a viable therapeutic strategy for patients with this high-risk AML subtype.
    MeSH term(s) Humans ; Child ; Homeodomain Proteins/genetics ; Homeodomain Proteins/metabolism ; Leukemia, Myeloid, Acute/drug therapy ; Leukemia, Myeloid, Acute/genetics ; Leukemia, Myeloid, Acute/pathology ; Transcription Factors ; Myeloid Ecotropic Viral Integration Site 1 Protein/genetics
    Chemical Substances Homeodomain Proteins ; Transcription Factors ; Myeloid Ecotropic Viral Integration Site 1 Protein
    Language English
    Publishing date 2023-10-26
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80069-7
    ISSN 1528-0020 ; 0006-4971
    ISSN (online) 1528-0020
    ISSN 0006-4971
    DOI 10.1182/blood.2023021359
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top